SILO PHARMA, INC.: 10-Q filed 2019-11-13
What SILO PHARMA, INC. reported in its quarterly report filed 2019-11-13 (fiscal Q3 2019): 28 published measures, 81 facts as tagged in accession 0001213900-19-023011.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2019-11-13
- Fiscal period
- fiscal Q3 2019
- Accession
- 0001213900-19-023011 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SILO PHARMA, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 386,530 | USD | |
| At 2018-12-31 | 855,417 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | -101,301 | USD | |
| At 2019-06-30 | 102,945 | USD | |
| At 2019-03-31 | 292,669 | USD | |
| At 2018-12-31 | 407,442 | USD | |
| At 2018-09-30 | 1,006,515 | USD | |
| At 2018-06-30 | 904,677 | USD | |
| At 2018-03-31 | 1,220,591 | USD | |
| At 2017-12-31 | 1,203,042 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 24,556 | USD | |
| At 2018-12-31 | 336,679 | USD | |
| At 2018-09-30 | 626,115 | USD | |
| At 2017-12-31 | 294,591 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -265,481 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -631,215 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -198,162 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -496,527 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | -501,520 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 431,524 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 268 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 268 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 2,656 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 186,741 | USD | 273 |
| 2018-01-01 to 2018-09-30 | -100,000 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | -2,273,725 | USD | |
| At 2018-12-31 | -1,642,510 | USD |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 23,467,632 | shares | 92 |
| 2019-01-01 to 2019-09-30 | 23,442,998 | shares | 273 |
| 2018-07-01 to 2018-09-30 | 50,104,180 | shares | 92 |
| 2018-01-01 to 2018-09-30 | 50,089,767 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -0.01 | USD/shares | 92 |
| 2019-01-01 to 2019-09-30 | -0.03 | USD/shares | 273 |
| 2018-07-01 to 2018-09-30 | 0 | USD/shares | 92 |
| 2018-01-01 to 2018-09-30 | -0.01 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -0.01 | USD/shares | 92 |
| 2019-01-01 to 2019-09-30 | -0.03 | USD/shares | 273 |
| 2018-07-01 to 2018-09-30 | 0 | USD/shares | 92 |
| 2018-01-01 to 2018-09-30 | -0.01 | USD/shares | 273 |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 87,485 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 203,722 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 30,000 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 115,000 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -242,507 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -606,946 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -81,182 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -292,145 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 157,090 | USD | |
| At 2018-12-31 | 625,977 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 94 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 864 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 87,831 | USD | |
| At 2018-12-31 | 47,975 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 242,693 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 607,132 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 81,182 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 292,145 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 99,580 | USD | |
| At 2018-12-31 | 26,973 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 186 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 186 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 23,492,540 | shares | |
| At 2018-12-31 | 23,417,450 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 2,170,075 | USD | |
| At 2018-12-31 | 2,047,610 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 29,440 | USD | |
| At 2018-12-31 | 29,440 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 23,560 | USD | |
| At 2018-12-31 | 34,031 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -265,481 | USD | 92 |
| 2019-04-01 to 2019-06-30 | -242,211 | USD | 91 |
| 2019-01-01 to 2019-03-31 | -123,523 | USD | 90 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 44,553 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 75,687 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 6,364 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 25,009 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -22,974 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -24,269 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -116,980 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -204,382 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 72,607 | USD | 273 |
Inspect the source
- Entity
- SILO PHARMA, INC. / CIK 0001514183
- Captured
- 2026-09-20T09:13:20.337Z
- SEC response SHA-256
b55b01ff5b31c52a933a54029f5fe837eae02333bd43de16acad37f51e3b67db
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001514183.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))